San Antonio, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) -- A study presented at RSNA and published in Academic Radiology has found that Seno Medical's Imagio® Breast Imaging System with opto-acoustic ...
San Antonio, Texas, Dec. 08, 2023 (GLOBE NEWSWIRE) -- A limited feasibility study presented at this year's San Antonio Breast Cancer Symposium (SABCS) found that Seno ...
Seno Medical, a San Antonio, Texas firm, has won FDA approval to introduce its Imagio device that utilizes opto-acoustic imaging to help physicians identify whether breast lesions are benign or ...
CHICAGO, Nov. 28, 2017 /PRNewswire/ -- Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using optoacoustic (OA/US) imaging to differentiate ...
Seno Medical Instruments (San Antonio), a company developing opto-acoustic technology as a new tool for diagnosing breast cancer, has completed active enrollment of subjects in its U.S.-based PIONEER ...
Non-line-of-sight (NLOS) imaging enables recovery of hidden scenes but is constrained by a speed-resolution trade-off in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results